In ER+PR+ breast tumors, the proportion of cells expressing these HRs is commonly higher than in the normal breast [46], thus the increased proportion of ER+/PR+ co-expressing cells might reflect a higher probability of each HR being expressed in the same cell. The gene discussed is PGR; the disease is breast neoplasm.